The Sleep Advice With Almost No Evidence Behind It

There is a drawer in my kitchen with three different sleep aids in it, and none of them are finished. A half-used bottle of melatonin gummies from two winters ago. A tin of valerian capsules a friend swore by and I never got through. A tea blend with a name prettier than what it actually does. If you have mentioned trouble sleeping to anyone in the last few years, there is a decent chance someone handed you the melatonin first. It is the reflex recommendation, the one every drugstore aisle stocks by the register. I just wanted to know what the research actually says about it.

What researchers found

A 2026 meta-analysis pooled seven randomized trials, 10 publications in total and 497 women combined, testing melatonin in perimenopausal and postmenopausal women ages roughly 49 to 63. Combined, the results did not show a statistically meaningful improvement in sleep quality. The honest complication sitting underneath that finding: only three of the seven trials actually measured sleep with any instrument; the rest looked at other outcomes entirely, and the doses tested ranged wildly, from 1 milligram up to 3 grams. That is not a small range. A finding this scattered doesn't prove melatonin does nothing. It means we don't have enough consistent data yet to say either way.

Valerian, the quieter option in that kitchen drawer, has one real trial behind it worth naming. A triple-blind, placebo-controlled study from 2011 gave 100 postmenopausal women with insomnia a valerian concentrate twice a day for four weeks. Using a standard sleep quality index, researchers found that 36 percent of the women reported a real improvement, compared with eight percent in the placebo group. That is a meaningful gap. It is also one study, on women aged 50 to 60, not yet repeated at a larger scale, and not the same as a settled consensus.

Where the data runs thin

Here is the part that is easy to skip past. The melatonin research doesn't say the supplement fails. The trials disagree with each other too much, and measure too little, to draw a firm line either way. Heterogeneity across those seven studies was very high by the researchers' own accounting. Meanwhile valerian, the option almost nobody mentions first, has the tidier single result, on a slightly older population than most of the women reading this. Neither fact makes a tidy headline, which might be why melatonin keeps getting handed out and valerian barely comes up.

What I keep coming back to is this: the price of a supplement and the volume of recommendation around it tell you nothing about how well it has actually been tested. In this particular case, the loudest, most purchased option has the weaker evidence behind it.

What this can look like in practice

I am not going to tell you what to take or how much of it. What the research supports is smaller and more useful than that: checking what has actually been studied before assuming the most familiar option is the best-supported one. My Sleep After 40 guide traces claims like these back to the trial behind them, the sample size, the population studied, and the year, so instead of guessing which bottle on the shelf is worth the money, you can see what's actually behind each one before you decide anything.

What's worth skipping

Skip assuming the most talked-about remedy is automatically the most tested one. This is a case where that assumption runs backward. And don't confuse "no clear effect found" with "proven not to work." Those are different claims, and the melatonin research lands squarely in the first one, not the second. And if sleeplessness has gone on for a while or feels severe, that is a conversation worth having with an actual doctor, not something a research roundup like this one can sort out for you.